A study released in May 2010 by the Canadian Medical Association Journal suggests use of
venlafaxine doubles the risk of miscarriage. Consequently,
venlafaxine should only be used during pregnancy if clearly needed. Prospective studies have not shown any statistically significant congenital malformations. There have, however, been some reports of self-limiting effects on newborn infants.